Toussaint Nigel D, Polkinghorne Kevan R, Kerr Peter G
Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia.
Hemodial Int. 2008 Apr;12(2):254-63. doi: 10.1111/j.1542-4758.2008.00262.x.
Cardiovascular (CV) disease is the most common cause of mortality in end-stage kidney disease (ESKD), and arterial stiffness, measured by pulse wave velocity (PWV), is an independent predictor of all-cause and CV mortality. B-type natriuretic peptide (BNP) levels are high in patients with CV disease and ESKD, and increases in BNP may also be a marker of CV risk. Regular exercise has many benefits on quality of life and physical strength and may also improve CV risk, but few studies have addressed the impact of exercise on CV risk in ESKD. We performed a prospective cross-over trial in 19 hemodialysis (HD) patients to assess the impact of regular exercise on surrogate markers of CV risk-arterial compliance and BNP levels. Exercise involved the use of a bicycle ergometer for minimum 30 min at each HD session for 3 months, with a 1-month washout period. Group A (n=9) exercised for the first 3 months only, while group B (n=10) performed no intradialytic exercise initially and exercised for 3 months at cross-over (month 4). Pulse wave velocity was performed using a SphygmoCor device, with concurrent measurements of BNP and other serum markers, at the commencement of the study, at 3 months, and on completion. The mean PWV (A: 10.4+/-3.1 m/s, B: 9.8+/-3.8 at baseline) showed a trend toward improvement with exercise (A: 8.7+/-2.7, p=0.07), and no significant change without (B: 10.5+/-3.6, p=0.31). After cross-over, there was an increase in PWV in group A with cessation of exercise (9.75+/-2.4, p=0.01 vs. 3 months) and an improvement in group B with exercise (9.33+/-2.3, p=0.11 vs. 3 months). When comparing PWV after 3 months of exercise vs. 3 months of no exercise (paired t test), there was a significant difference in favor of exercise (9.04+/-0.59 vs. 10.16+/-0.74, p=0.008). The mean BNP levels following 3 months of exercise were also lower than those after 3 months of no exercise (504.4+/-101.2 vs. 809.4+/-196.1[N<100], p=0.047). There was an overall improvement in PWV, and to a lesser extent BNP levels, with 3 months of intradialytic exercise compared with no exercise, suggesting that regular exercise in ESKD may be associated with improvements in arterial compliance and a reduction in CV risk.
心血管(CV)疾病是终末期肾病(ESKD)最常见的死亡原因,通过脉搏波速度(PWV)测量的动脉僵硬度是全因死亡率和心血管死亡率的独立预测指标。CV疾病和ESKD患者的B型利钠肽(BNP)水平较高,BNP升高也可能是心血管风险的标志物。规律运动对生活质量和体力有诸多益处,还可能改善心血管风险,但很少有研究探讨运动对ESKD患者心血管风险的影响。我们对19例血液透析(HD)患者进行了一项前瞻性交叉试验,以评估规律运动对心血管风险替代标志物——动脉顺应性和BNP水平的影响。运动方式为在每次HD治疗期间使用自行车测力计至少30分钟,持续3个月,有1个月的洗脱期。A组(n = 9)仅在最初3个月进行运动,而B组(n = 10)最初不进行透析内运动,在交叉期(第4个月)进行3个月运动。在研究开始时、3个月时和结束时,使用SphygmoCor设备测量脉搏波速度,并同时测量BNP和其他血清标志物。平均PWV(A组:基线时10.4±3.1 m/s,B组:9.8±3.8)显示运动后有改善趋势(A组:8.7±2.7,p = 0.07),不运动则无显著变化(B组:10.5±3.6,p = 0.31)。交叉后,A组停止运动后PWV升高(9.75±2.4,与3个月时相比p = 0.01),B组运动后PWV改善(9.33±2.3,与3个月时相比p = 0.11)。比较运动3个月与不运动3个月后的PWV(配对t检验),运动组有显著差异(9.04±0.59 vs. 10.16±0.74,p = 0.008)。运动3个月后的平均BNP水平也低于不运动3个月后的水平(504.4±101.2 vs. 809.4±196.1[N<100],p = 0.047)。与不运动相比,3个月的透析内运动使PWV总体得到改善,BNP水平改善程度较小,这表明ESKD患者规律运动可能与动脉顺应性改善和心血管风险降低有关。